| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 |
|---|---|---|---|---|---|---|
Cash flows from operating activities | ||||||
Net loss | ||||||
-5,450 | -4,338 | -2,846 | - | -2,490 | -2,394 | -1,695 |
Adjustment to reconcile net loss to net cash used in operating activities: | ||||||
Bad debt expense | ||||||
208 | 471 | 252 | 189 | 54 | 53 | 47 |
Stock-based compensation expense | ||||||
301 | 331 | 161 | - | - | - | - |
Changes in operating assets and liabilities: | ||||||
Accounts receivable | ||||||
-234 | -287 | 1,508 | 275 | 1,154 | 391 | -151 |
Prepaid expenses and other current assets | ||||||
631 | 238 | 292 | 146 | 132 | -95 | 167 |
Accounts payable | ||||||
- | 70 | 281 | - | - | 310 | 293 |
Accounts payable and accrued liabilities | ||||||
1,327 | 70 | -7 | -1,102 | 892 | 296 | 40 |
Deferred revenue | ||||||
-101 | -58 | 278 | -281 | 564 | -490 | 362 |
Net cash used in operating activities | ||||||
-4,518 | -3,403 | -3,679 | -2,690 | -2,868 | -2,521 | -967 |
Cash flows from financing activities | ||||||
Cash received in connection with exercise of warrants | ||||||
0 | 4 | 4,242 | - | - | - | - |
Cash received in connection with issuance of shares | ||||||
- | - | - | 0 | 0 | 0 | 10,000 |
Net cash provided by financing activities | ||||||
0 | 4 | 4,242 | 0 | 0 | 0 | 10,000 |
Net change in cash and restricted cash | ||||||
-4,470 | -3,649 | 562 | 16,152 | -2,868 | -2,521 | 9,032 |
Cash paid for interest | ||||||
- | 0 | 1 | - | - | 0 | 0 |